BOLT Stock Analysis: Buy, Sell, or Hold?
BOLT - Bolt Biotherapeutics, Inc. Common Stock
$4.67
0.08 (1.74%)
▲
5d:
-7.71%
30d:
+3.55%
90d:
-19.06%
HOLD
LOW Confidence
Analysis Updated: May 8, 2026 12:00 AM ET
Earnings: May 11, 2026
1d
Get Alerted When BOLT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: BOLT shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: BOLT shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: BOLT is currently trading at $4.67, which is considered fair relative to its 30-day fair value range of $4.51 to $5.03.
Technical Outlook: Technically, BOLT is in a downtrend. Immediate support is located at $4.50, while resistance sits at $5.20.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $29.00 (+521.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, BOLT is in a downtrend. Immediate support is located at $4.50, while resistance sits at $5.20.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $29.00 (+521.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$4.51 -
$5.03
Company Quality Score
50/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
74.7%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 521.0% below Wall St target ($29.00)
- CAUTION: Recommendation downgraded due to -7.7% 5-day decline
Trading Range Analysis
30-Day Trading Range
$4.51 -
$5.03
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$4.50
Resistance Level
$5.20
Current Trend
Downtrend
Technical data as of
May 8, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.19
Wall Street Target
$29.00
(+521.0%)
Revenue Growth (YoY)
90.1%
Share & Embed Analysis
Last updated: May 09, 2026 12:11 PM ET
Data refreshes hourly during market hours. Next update: 1:11 PM
Data refreshes hourly during market hours. Next update: 1:11 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BOLT showing a specific setup today?
Insider Activity (6 Months)
2
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Sarah Nemec
BUY
125 shares
2025-12-05
William P Quinn
BUY
125 shares
2025-12-05
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$408 | 58 HOLD |
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$27 | 53 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$230 | 55 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 57 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$109 | 62 BUY |
